Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples

NCT01614145 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-04-20

No results posted yet for this study

Summary

Multicentre, diagnostic study evaluating the performance of an aspergillus-specific PCR in cerebrospinal fluid samples of immunocompromised patients for identification of central nervous system aspergillosis.

Conditions

  • Focus: Immunocompromised Individuals at High Risk of Aqcuiring Invasive Aspergillosis

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Dieter Buchheidt, MD · Germany: Mannheim University Hospital, University of Heidelberg

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614145 on ClinicalTrials.gov